Emergent BioSolutions Reports Financial Results For 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Emergent BioSolutions Inc. (NYSE: EBS) announced today its financial results for the fourth quarter and full year ended December 31, 2013.

For the full year 2013, total revenues were $312.7 million as compared to $281.9 million in 2012, and GAAP net income was $31.1 million, or $0.86 per basic share, as compared to $23.5 million, or $0.65 per basic share, in 2012. Factoring in adjustments that exclude certain acquisition related, restructuring and non-cash impairment charges of approximately $7.8 million in 2013 and approximately $10.3 million in 2012, non-GAAP adjusted net income was $36.2 million in 2013 and $30.2 million in 2012 (see “Reconciliation of GAAP to Non-GAAP Net Income” for a definition of terms and a reconciliation table).

Help employers find you! Check out all the jobs and post your resume.

Back to news